Researchers have identified a set of drug-like compounds, including a common ingredient in throat lozenges, that can help protect mitochondria from the stresses associated with neurodegenerative diseases.
In a virtual reality experiment, participants recovered faster from a small electric shock when they could smell natural scents than when they could smell urban odors.
When it comes to Alzheimer’s, what happens first: beta amyloid plaques, or the visible personality and cognitive changes common with the disease? Researchers have long believed that amyloid drives neurodegeneration in the brain. But it’s possible that subtle changes in a person’s thinking abilities may actually precede the development of beta-amyloid protein, providing more clues to the complexity of the disease, according to a new study.
Cannabis can trigger brain cell growth in humans says new study
Yoga Therapist and Brain Longevity Specialist Amy Di Lillo, C-IAYT, E-RYT, YACEP will be hosting a three-part Brain Longevity Series covering the 4 Pillars of Alzheimer’s Prevention®. The lectures will be held once a month in the Cohasset Elder Affairs building, starting January 13th located at Willcutt Commons: 91 Sohier Street, Cohasset, Massachusetts.
Pulling an all-nighter or getting fewer hours of sleep than normal may have more consequences than simply suffering fatigue during the work day. According to a new small study, losing just one night of sleep may increase a biomarker associated with Alzheimer’s disease.
Check out our 2019 MMYTT graduate Andrea as she rocks it on the podcast
When it comes to eating healthy, we’re always on the hunt for lesser-known powerhouse veggies to incorporate into our diets. We asked neurologist and mbg Collective member David Perlmutter, M.D., what food he wants us all to eat in 2020, and he answered with a resounding (and fairly surprising) vegetable.
A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer’s disease. The researchers suggest this “dementia vaccine” is now ready for human trials, and if successful could become the “breakthrough of the next decade.”
Scientists are increasingly certain that Alzheimer’s and other dementias are caused by many factors. Genetics certainly play a major role, but researchers are increasingly focusing on other issues such as inflammation, blood pressure and type 2 diabetes, among others. Even conditions such as untreated depression and anxiety are believed to contribute to the likelihood of developing dementia.